1. Home
  2. BZUN vs ORGO Comparison

BZUN vs ORGO Comparison

Compare BZUN & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$3.60

Market Cap

164.5M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

BUY

Current Price

$0.98

Market Cap

127.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BZUN
ORGO
Founded
2007
1985
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
127.6M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
BZUN
ORGO
Price
$3.60
$0.98
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
★ $4.58
$2.00
AVG Volume (30 Days)
369.5K
★ 765.7K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1600.00
EPS
★ N/A
N/A
Revenue
N/A
★ $564,169,000.00
Revenue This Year
$8.08
N/A
Revenue Next Year
$7.45
$37.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 17.04
52 Week Low
$2.07
$0.93
52 Week High
$3.92
$7.08

Technical Indicators

Market Signals
Indicator
BZUN
ORGO
Relative Strength Index (RSI) 59.76 23.69
Support Level $2.57 N/A
Resistance Level N/A $2.57
Average True Range (ATR) 0.22 0.08
MACD 0.00 -0.01
Stochastic Oscillator 56.08 11.21

Price Performance

Historical Comparison
BZUN
ORGO

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: